نتائج البحث - "TP Lodise"

المؤلفون: Lodise TP; Albany College of Pharmacy and Health Sciences, Albany, New York., Bhavnani SM; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York., Ambrose PG; Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York., Sader HS; JMI Laboratories, North Liberty, Iowa., Andes DR; Department of Medicine, Department of Medical Microbiology and Immunology, School of Medicine and Public Health and School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin., Pogue JM; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 21. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Full Text Finder

5

دورية أكاديمية

Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens.

المؤلفون: Lodise TP; Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA., Kaye KS; Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Santerre Henriksen A; Maxel Consulting ApS, Jyllinge, Denmark., Kahlmeter G; Department of Clinical Microbiology, Central Hospital, Växjö, Sweden.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2024 May 24; Vol. 11 (6), pp. ofae296. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Full Text Finder

6

دورية أكاديمية

Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.

المؤلفون: Straub TJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Lombardo MJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Bryant JA; Seres Therapeutics, Cambridge, Massachusetts, USA., Diao L; Seres Therapeutics, Cambridge, Massachusetts, USA., Lodise TP; Albany College of Pharmacy and Health Sciences, Albany, New York, USA., Freedberg DE; Division of Digestive and Liver Diseases, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York, USA., Wortman JR; Seres Therapeutics, Cambridge, Massachusetts, USA., Litcofsky KD; Seres Therapeutics, Cambridge, Massachusetts, USA., Hasson BR; Seres Therapeutics, Cambridge, Massachusetts, USA., McGovern BH; Seres Therapeutics, Cambridge, Massachusetts, USA., Ford CB; Seres Therapeutics, Cambridge, Massachusetts, USA., Henn MR; Seres Therapeutics, Cambridge, Massachusetts, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Apr 10; Vol. 78 (4), pp. 833-841.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Clostridioides difficile*/genetics , Microbiota* , Clostridium Infections*/microbiology, Adult ; Humans ; Female ; Aged ; Male ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Fecal Microbiota Transplantation ; Drug Resistance, Bacterial ; Bacteria ; Firmicutes

Full Text Finder

7

دورية أكاديمية

Machine Learning-Led Optimization of Combination Therapy: Confronting the Public Health Threat of Extensively Drug Resistant Gram-Negative Bacteria.

المؤلفون: Smith NM; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Nguyen TD; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Lodise TP; Albany College of Pharmacy and Health Sciences, Troy, New York, USA., Chen L; Center for Discovery and Innovation, Hackensack-Meridian Health, Nutley, New Jersey, USA., Kaur JN; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Klem JF; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Boissonneault KR; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Holden PN; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA., Roach DR; San Diego State University, San Diego, California, USA., Tsuji BT; School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 896-905. Date of Electronic Publication: 2023 Dec 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Polymyxin B* , Aztreonam*/pharmacology, Animals ; Humans ; Public Health ; Anti-Bacterial Agents/adverse effects ; Gram-Negative Bacteria

View record at Wiley

Full Text Finder

8

دورية أكاديمية

Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals.

المؤلفون: Lodise TP; Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA., Garey KW; Department of Pharmacy Practice, University of Houston College of Pharmacy, Houston, Texas, USA., Aram JA; Melinta Therapeutics, Parsippany, New Jersey, USA., Nathanson BH; OptiStatim, LLC, Longmeadow, Massachusetts, USA.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 03; Vol. 11 (1), pp. ofad703. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Full Text Finder

9

دورية أكاديمية

Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer β-lactam or β-lactam/β-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimen.

المؤلفون: Lodise TP; Albany College of Pharmacy and Health Sciences, Department of Pharmacy Practice, 106 New Scotland Avenue, Albany, NY, USA., Yucel E; Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, USA., Obi EN; Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, USA., Watanabe AH; Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, USA., Nathanson BH; OptiStatim LLC, 25 Willow Circle, Longmeadow, MA, USA.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jan 03; Vol. 79 (1), pp. 82-95.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: beta-Lactamase Inhibitors*/adverse effects , Acute Kidney Injury*/chemically induced, Adult ; Humans ; beta-Lactams ; Carbapenems/therapeutic use ; Polymyxins ; Lactams ; Aminoglycosides/adverse effects ; Retrospective Studies ; Incidence ; Anti-Bacterial Agents/pharmacology

Full Text Finder

10

دورية أكاديمية

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.

المؤلفون: Doernberg SB; Division of Infectious Diseases, Department of Medicine, University of California, SanFrancisco, California, USA., Arias CA; Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Weill-Cornell Medical College, New York, New York, USA., Altman DR; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, NewYork, New York, USA., Babiker A; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Boucher HW; Tufts University School of Medicine, Medford, Massachusetts, USA., Creech CB; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Cosgrove SE; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Evans SR; Department of Biostatistics, George Washington University, Washington, District of Columbia, USA., Fowler VG; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Fritz SA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Hamasaki T; Biostatistics Center, George Washington University, Rockville, Maryland, USA., Kelly BJ; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Leal SM; Department of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Liu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Lodise TP; Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York, USA., Miller LG; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.; Division of Infectious Diseases, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Munita JM; Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile.; Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance, Santiago, Chile., Murray BE; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Pettigrew MM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA., Ruffin F; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Scheetz MH; Pharmacometrics Center of Excellence, College of Pharmacy, Midwestern University, Downers Grove, Illinois, USA., Shopsin B; Division of Infectious Diseases, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.; Department of Microbiology, NewYork University Grossman School of Medicine, New York, New York, USA., Tran TT; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA., Turner NA; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Williams DJ; Division of Hospital Medicine, Department of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tennessee, USA., Zaharoff S; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA., Holland TL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

مؤلفون مشاركون: Antibacterial Resistance Leadership Group

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Oct 16; Vol. 77 (Suppl 4), pp. S295-S304.

نوع المنشور: Review; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Methicillin-Resistant Staphylococcus aureus* , Gram-Positive Bacterial Infections*/drug therapy , Gram-Positive Bacterial Infections*/microbiology , Sepsis*/drug therapy, Humans ; Child ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Leadership ; Quality of Life ; Gram-Positive Bacteria

Full Text Finder

تنقيح النتائج